You may have seen recent reports about a link between breast implants and a rare form of non-Hodgkin’s lymphoma called Breast Implant Associated Large Cell Anaplastic Lymphoma (BIA-ALCL).
The risk of developing this cancer is very low but it does seem to vary depending upon the type of implant used.
In light of recent studies into BIA-ALCL, some manufacturers have withdrawn their implants and the Therapeutic Goods Administration (TGA) has suspended the use of others.
The Therapeutic Goods Administration (TGA), which is the national regulatory body on therapeutic goods, advise that there is no requirement to remove or exchange any current implants unless you are experiencing symptoms such as pain, swelling, leaking or rupture.
The Australian Society of Plastic Surgeons (ASPS) and the Australasian Society of Aesthetic Plastic Surgeons (ASAPS) support the TGA decision in the interest of patient safety.
The latest information from the TGA including advice for patients can be found at https://www.tga.gov.au/alert/breast-implants-and-anaplastic-large-cell-lymphoma
Guidance for Patients
I have used Mentor implants almost exclusively for the past 12 years (these implants have not been affected as part of the TGA review). As your surgeon, I can understand that you may have concerns and questions about your breast implants. If you would like to know what implants have been used in your surgery, please call my office on 93800311 or email email@example.com.